Evidence map›Paper›PMID 40298995›Full record

ArticleAnnals of hematology2025

A rare case of type 2A von Willebrand disease with compound heterozygous mutation.

Li-Jing Wang, Qi Gao, Bo Pang, Tao Wu, Xuyang Zhang, Hansheng Fang, Haidan Chen, Huili Cai

Abstract readCase Reports
In one paragraph

Article in Annals of hematology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Li-Jing WangDepartment of Hematology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, Hubei, 443003, China.
Qi GaoDepartment of The Second Internal Medicine, Hubei Provincial Corps Hospital of Chinese People' s Armed Police Force, Wuhan, Hubei, China.
Bo PangDepartment of Hematology, The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University, Wuhan, Hubei, China.
Tao WuDepartment of Hematology, The Sixth Hospital of Wuhan, Affiliated Hospital of Jianghan University, Wuhan, Hubei, China.
Xuyang ZhangDepartment of Hematology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, Hubei, 443003, China.
Hansheng FangDepartment of Hematology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, Hubei, 443003, China.
Haidan ChenDepartment of Spinal Surgery, The First College of Clinical Medical Science, China Three Gorges University, Yichang, Hubei, China.
Huili CaiDepartment of Hematology, The First College of Clinical Medical Science, China Three Gorges University, Yichang, Hubei, 443003, China. caihuili@ctgu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

von Willebrand disease (VWD) is defined by a quantitative or qualitative deficiency of von Willebrand factor, which impairs platelet adhesion and aggregation. Here we describe a rare case of type 2A VWD with compound heterozygous mutation. A 27-year-old girl presented with oral bleeding for two days after dental surgery. A systemic physical examination turned up unremarkable. Type 2 von Willebrand disease was confirmed by laboratory tests. Further genetic investigation revealed the existence of compound mutations of VWF (von Willebrand factor) gene, inherited separately from her parents. Interestingly, her mother presented decreased VWF antigen and activity, but that was not found in her father.

Indexed as

HeterozygoteMutationvon Willebrand Disease, Type 2von Willebrand FactorAdultFemaleHumansvon Willebrand FactorHeterozygous mutationvon Willebrand diseasevon Willebrand factor

Identifiers

PMID40298995
PMCPMC12141377

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.